Stay updated with breaking news from Recent Updates. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Supply constraints for the artificial intelligence (AI) hardware market are expected to continue in 2024, which could be good news for AI chip investors.
Nvidia is confident that it can grow revenue in 2024 and 2025.
Matthew Lunning, DO, discusses recent data on bispecific T-cell engagers as third-line and beyond therapy for FL.
Peter Martin, MD, discusses recent data on tazemetostat, an EZH2 inhibitor, as third-line and beyond therapy for FL.
Mobileye is not the only semiconductor stock to give a weaker-than-expected outlook.